| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 17.05.
| Technologie von St. Jude Medical für renale Denervierung sorgt für signifikante Senkung des Blutdrucks | | 45 | Business Wire |
| Einsatz der Technologie EnligHTN führte zu einer Senkung des
systolischen Blutdrucks um durchschnittlich 28 mmHg nach einem Monat
Studie weist doppelt so hohe...
Mehr lesen zu:
Technologie von St. Jude Medical für renale Denervierung sorgt für signifikante Senkung des Blutdrucks | |
| 16.05.
| An Exciting New Technology That Could Take Pressure Off St. Jude Medical | | - | Seeking Alpha |
| 16.05.
| St. Jude Medical (STJ) Presents Significant Data for TAVI Tech, AMPLATZER Cardiac Plug | | 1 | StreetInsider.com |
| 16.05.
| Key Clinical Data for St. Jude Medical's Structural Heart Technologies Revealed at EuroPCR | | 27 | Business Wire |
| St. Jude Medical, Inc. (NYSE:STJ), a global medical device company,
today announced that significant clinical data for its structural heart
portfolio is being presented...
Mehr lesen zu:
Key Clinical Data for St. Jude Medical's Structural Heart Technologies Revealed at EuroPCR | |
| 16.05.
| Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure | | 48 | Business Wire |
| Use of EnligHTN technology resulted in a 28 point reduction of systolic
blood pressure on average after 1 month
Trial showed double the reduction in blood...
Mehr lesen zu:
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure | |
| 15.05.
| St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension | | 15 | Business Wire |
| Decades of experience in ablation technologies used to develop the
industry's first multi-electrode technology for renal denervation
St. Jude Medical...
Mehr lesen zu:
St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension | |
| 15.05.
| St. Jude (STJ) Gets CE Mark for EnligHTN | | 1 | StreetInsider.com |
| 15.05.
| St. Jude Medical kündigt Zulassung und Launch des EnligHTN-Systems zur Behandlung von Bluthochdruck durch renale Denervierung in Europa an | | 32 | Business Wire |
| Jahrzehntelange Erfahrungen mit Ablationstechnologien haben zur
Entwicklung der branchenweit ersten Technologie für die renale
Denervierung mit mehreren Elektroden geführt
...
Mehr lesen zu:
St. Jude Medical kündigt Zulassung und Launch des EnligHTN-Systems zur Behandlung von Bluthochdruck durch renale Denervierung in Europa an | |
| 15.05.
| St. Jude Medical Announces European Approval, Launch Of EnligHTN System | | 36 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical, Inc. (STJ) announced CE Mark
approval and launch of its EnligHTN renal denervation system during EuroPCR.
Renal denervation is a specialized ablation...
Mehr lesen zu:
St. Jude Medical Announces European Approval, Launch Of EnligHTN System | |
| 15.05.
| St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension | | 53 | Business Wire |
| Decades of experience in ablation technologies used to develop the
industry's first multi-electrode technology for renal denervation
St. Jude Medical...
Mehr lesen zu:
St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal Denervation System for Treatment of Hypertension | |
| 14.05.
| St. Jude Medical rises on Goldman Sachs upgrade | | - | Yahoo-USA |
| 14.05.
| St. Jude Medical setzt starke Präsentation von Technologien zur PCI-Optimierung auf der EuroPCR fort | | 19 | Business Wire |
| Mit neuen Technologien, Symposien und einer FAME-II-Datenpräsentation
bleibt St. Jude Medical bei der Optimierung perkutaner
Koronarinterventionen (PCI) weiterhin an der...
Mehr lesen zu:
St. Jude Medical setzt starke Präsentation von Technologien zur PCI-Optimierung auf der EuroPCR fort | |
| 14.05.
| St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR | | 23 | Business Wire |
| New technology, symposia and a FAME II data presentation keep St. Jude
Medical at the forefront of PCI Optimization
St. Jude Medical, Inc. (NYSE:STJ)...
Mehr lesen zu:
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR | |
| 14.05.
| Goldman Sachs stuft St Jude Medical von neutral auf buy. | | 30 | BörseGo |
| Goldman Sachs stuft St Jude Medical von neutral auf buy.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
Goldman Sachs stuft St Jude Medical von neutral auf buy. | |
| 11.05.
| The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Cost Plus, Target, Wal-Mart and St. Jude Medical | | 42 | PR Newswire |
| CHICAGO, May 11, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Cost Plus, Target, Wal-Mart and St. Jude Medical | |
| 11.05.
| St. Jude: ICD Therapy Improves Long-term Survival Of Patients With Heart Failure | | 45 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical, Inc. (STJ) announced results of the
SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study
at Heart Rhythm 2012, the Heart...
Mehr lesen zu:
St. Jude: ICD Therapy Improves Long-term Survival Of Patients With Heart Failure | |
| 10.05.
| St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study; Confirms ICD Therapy Improves Long-Term Survival of Patients with Heart Failure | | - | Benzinga.com |
| 10.05.
| St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study | | 31 | Business Wire |
| Study confirms ICD therapy improves long-term survival of patients with
heart failure
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company...
Mehr lesen zu:
St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up Study | |
| 10.05.
| Critical Alerts For JP Morgan, CA Technologies, St Jude Medical, Bed Bath & Beyond, and Sina Corp. Released By InvestorsObserver | | 31 | PR Newswire |
| CHICAGO, May 10, 2012 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JPM, CA, STJ, BBBY, and SINA.
To see what our analysts have discovered about these stocks read the InvestorsObserver's...
Mehr lesen zu:
Critical Alerts For JP Morgan, CA Technologies, St Jude Medical, Bed Bath & Beyond, and Sina Corp. Released By InvestorsObserver | |
| 09.05.
| St. Jude Medical Gets FDA Approval For Ellipse ICD | | 42 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical, Inc. (STJ) announced FDA approval
of its Ellipse implantable cardioverter defibrillator, or ICD.ICDs are advanced implantable devices that treat potentially...
Mehr lesen zu:
St. Jude Medical Gets FDA Approval For Ellipse ICD | |
